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Abstract
© Schattauer 2014 Despite optimal therapy, the morbidity and mortality of patients presenting
with an acute myocardial infarction (M1) remain significant, and the initial mechanistic trigger of
myocardial “ischaemia/reperfusion (1/R) injury” remains greatly unexplained. Here we show that
factors released from the damaged cardiac tissue itself, in particular extracellular RNA (eRNA)
and tumour-necrosis-factor α (TNF-α), may dictate 1/R injury. In an experimental in vivo mouse
model  of  myocardial  1/R  as  well  as  in  the  isolated  1/R  Langendorff-perfused  rat  heart,
cardiomyocyte death was induced by eRNA and TNF-α. Moreover, TNF-α promoted further eRNA
release especially under hypoxia, feeding a vicious cell damaging cycle during 1/R with the
massive  production  of  oxygen  radicals,  mitochondrial  obstruction,  decrease  in  antioxidant
enzymes and decline of cardiomyocyte functions. The administration of RNase1 significantly
decreased  myocardial  infarction  in  both  experimental  models.  This  regimen  allowed  the
reduction in cytokine release, normalisation of antioxidant enzymes as well as preservation of
cardiac tissue. Thus, RNase1 administration provides a novel therapeutic regimen to interfere
with the adverse eRNA-TNF-α interplay and significantly reduces or prevents the pathological
outcome of ischaemic heart disease.
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